Europe Non-Emergency Medical Transportation Market Report 2031 by Segments, Geography, Dynamics, Recent Developments, and Strategic Insights
Europe Non-Emergency Medical Transportation Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, and Others), Facility (Intra-Facility and Inter-Facility), Application (Dialysis, Routine Doctor Visits, Mental Health Related Appointments, Rehabilitation, and Others), and End User (Hospitals and Clinics, Nursing Homes, Homecare Settings, MCO and State Agencies, Healthcare Payers, and Others)
Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031- Report Date : Nov 2025
- Report Code : TIPRE00041643
- Category : Life Sciences
- Status : Published
- Available Report Formats :

- No. of Pages : 204
The Europe Non-Emergency Medical Transportation Market size is expected to reach US$ 9,037.6 Million by 2031 from US$ 4,786.3 Million in 2024. The market is estimated to record a CAGR of 9.5% from 2025 to 2031.
Executive Summary and Europe Non-Emergency Medical Transportation Market Analysis:
The European non-emergency medical transportation (NEMT) market, divided into the UK, Germany, France, Italy, Spain, and the Rest of Europe, is growing consistently and is the second-largest market in the world. The sector mainly grows with the rising incidence of chronic and life-threatening diseases like cancer, cardiovascular disease, and renal disease, which necessitate patients to visit hospitals and clinics repeatedly. The area's fast-deteriorating population structure and increasing number of people with physical impairments are also adding to the increasing need for safe, accessible, and reliable transportation services.
Germany and the UK lead the market with highly developed healthcare systems, well-established reimbursement models, and strong patient mobility awareness. Southern European countries are demonstrating gradual growth based on government healthcare programs. Further, integration of technology in scheduling, tracking, and fleet management is increasing service effectiveness and patient satisfaction in Europe.
Customize This Report To Suit Your Requirement
Get FREE CUSTOMIZATIONEurope Non-Emergency Medical Transportation Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Non-Emergency Medical Transportation Market Segmentation Analysis:
- By Service Type, the Europe Non-Emergency Medical Transportation Market is segmented into Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, and Others. Private Pay Patient Transportation held the largest share of the market in 2024.
- By Facility, the Europe Non-Emergency Medical Transportation Market is segmented into Intra-Facility and Inter-Facility. Inter-Facility held a larger share of the market in 2024.
- By Application, the Europe Non-Emergency Medical Transportation Market is segmented into Dialysis, Routine Doctor Visits, Mental Health Related Appointments, Rehabilitation, and Others. Mental Health Related Appointments held the largest share of the market in 2024.
- By End User, the Europe Non-Emergency Medical Transportation Market is segmented into Hospitals and Clinics, Nursing Homes, Homecare Settings, MCO and State Agencies, Healthcare Payers, and Others. Hospitals and Clinics held the largest share of the market in 2024.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 4,786.3 Million |
| Market Size by 2031 | US$ 9,037.6 Million |
| CAGR (2025 - 2031) | 9.5% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Service Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
Europe Non-Emergency Medical Transportation Market Players Density: Understanding Its Impact on Business Dynamics
The Europe Non-Emergency Medical Transportation Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
- Get the Europe Non-Emergency Medical Transportation Market top key players overview
Europe Non-Emergency Medical Transportation Market Outlook
Chronically ill patients can be the main concern for family members. In addition to taking care of recurring medical expenses, family members also need to be proactive in arranging transportation, as these patients require regular access to life-saving health services. Managing chronic diseases necessitates regular clinician visits, access to medications, and adjustments to treatment plans to ensure evidence-based care. However, without proper transportation, delays in clinical interventions are unavoidable. Such delays in care can cause exacerbations of chronic conditions or unmet healthcare needs, ultimately resulting in adverse health outcomes. This highlights the urgent need for reliable patient transportation, particularly for patients with terminal illnesses requiring consistent post-acute care management. The World Health Organization (WHO) reported in 2023 that the population aged 60 and older is expected to reach 2.1 billion by 2050. This increase will come with a sharp rise in chronic diseases like diabetes, heart disease, and arthritis. As a result, more people need non-emergency medical transportation around the world. Patients often require regular access to healthcare facilities for ongoing treatment and management. Therefore, the aging population and chronic conditions are major factors driving the growth of non-emergency medical transportation services.
While some people might need therapies on a daily basis, many visit their physicians for weekly consultations. Additionally, several chronic diseases, such as arthritis, heart disease, and neurological conditions, can result in temporary or permanent immobility. Many individuals suffering from chronic conditions find it difficult to drive or use public transportation to access healthcare. Arranging a separate car may not be viable, especially for families belonging to low-income groups who do not own any vehicle. NEMT proves to be of great help to people, as these transportation options are cost-effective and specifically designed to cater to people with mobility challenges and medical needs. In addition, the easy availability of NEMT allows individuals with chronic medical conditions to access life-sustaining treatments and healthcare services without any delay.
As the population ages, the demand for healthcare services has skyrocketed. There is an increase in older adults requiring medical care, ranging from routine check-ups to treatments for chronic conditions (diabetes, hypertension, arthritis, and physical therapy). Any missed appointments can cause disease progression and limit the patient's ability to manage their conditions. Older adults often face mobility challenges, making reliable transportation with specialized vehicles and trained personnel essential to ensure they can access necessary medical appointments. NEMT provides a reliable way to attend appointments, reducing the possibility of missing appointments due to transportation barriers. Thus, the increase in the aging population and chronic conditions bolsters the growth of the non-emergency medical transportation market.
Europe Non-Emergency Medical Transportation Market Country Insights
By country, the Europe Non-Emergency Medical Transportation Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2024.
According to the UN Population Division Report, Germany's population aged 65 years and older is projected to increase by 41% and is expected to reach 24 million by 2050, accounting for approximately one-third of the total population. Germany is a leading figure in the fight against mental illness in Europe. The country has established ways for the diagnosis and treatment of mental illness in citizens and has prioritized the mental health of all Germans since the 1990s. Germany has a similar rate of mental illness to other developed nations, with approximately 31% of Germans diagnosed with at least one mental disorder. Unlike most developed nations, depression and anxiety are the highest among adults, but they are formed at a young age. According to the German Center for Mental Health (DZPG) 2024 report, up to 20% of the children and adolescents in Germany suffer from mental disorders.
According to the German Federal Statistical Office, 7.8 million severely disabled people lived in Germany in 2022, accounting for 9.4% of the total German population.
Europe Non-Emergency Medical Transportation Market Company Profiles
Some of the key players operating in the market include AMR, ABC Non-Emergency Medical Transportation, LLC, MTM, Inc., Xpress Transportation, CJ Medical Transportation, VERIDA, Elite Medical Transport, Acadian Ambulance Service, Crothall Healthcare, ModivCare, Ride Health, Roundtrip, Transdev, One Call, Medical Answering Services, LLC, Abba Medical Transportation, LLC, Able Medical Transportation, Inc., Life Ride, Stellar Transport, and Mobility Transportation Services, Inc.
These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Europe Non-Emergency Medical Transportation Market Research Methodology
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.Primary Research
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For